The stoke reached a high of $359. Stifel Nicolaus analysts have raised Crowdstrike’s price target from $375.00 to $400.00 ...

In a report released yesterday, Stephen Willey from Stifel Nicolaus maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report). The ...

In a report released yesterday, Alex Thompson CFA from Stifel Nicolaus maintained a Hold rating on Travere Therapeutics (TVTX – Research ...

Discover three oversold biotech/biopharma stocks to watch amidst market volatility and the JP Morgan Healthcare event in San ...

D-Wave Quantum (NYSE:QBTS) said in a regulatory filing on Friday that it entered a sales agreement with agents, under which ...

Stifel Financial Cor this week announced that Schluckebier Hood Wealth Management Group of its Stifel, Nicolaus & Company, Incorporated broker-dealer subsidiary has been named to Forbes’ 2025 ...

Wendy’s (NASDAQ:WEN – Free Report) had its price target reduced by Stifel Nicolaus from $18.00 to $17.00 in a report issued on Friday,Benzinga reports. They currently have a hold rating on the ...

Following closing of its transaction with Telix Pharmaceuticals, ImaginAb, Inc. will be focused on developing its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials ...

Jack in the Box (NASDAQ:JACK – Get Free Report) had its price objective reduced by research analysts at Stifel Nicolaus from ...

Cloud computing enables companies to store their infrastructures remotely using the Internet, ultimately reducing costs and ...

In October 2024, the Seward County Commission adopted a resolution authorizing the issuance of general obligation (GO) bonds ...

The broker-dealer Stifel Nicolaus & Co. Inc. is the home to Stifel Financial’s network of retail financial advisors, including Roberts, who has worked there since 2016. In the two complaints ...